Mr. Theodore R. Schroeder is an Independent Director at Collegium Pharmaceutical, Inc., an Independent Director at Otonomy, Inc., a President, Chief Executive Officer & Director at Zavante Therapeutics, Inc. and an Independent Director at Cidara Therapeutics, Inc.
He is on the Board of Directors at Collegium Pharmaceutical, Inc., Otonomy, Inc., Zavante Therapeutics, Inc., Cidara Therapeutics, Inc., BIOCOM and Sharp Hospital Foundation. Mr. Schroeder was previously employed as an Independent Director by Trius Therapeutics, Inc., a President, Chief Executive Officer & Director by Cadence Pharmaceuticals, Inc., a Senior VP-North American Sales & Marketing by Elan Pharmaceuticals, Inc., a Senior Director-Marketing Hospital Products by Dura Pharmaceuticals, Inc., and a Principal by Bristol-Myers Squibb Co.
He also served on the board at Hyperion Therapeutics, Inc. and Incline Therapeutics, Inc.
He received his undergraduate degree from Rutgers State University of New Jersey.